Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cardinal Health 414, LLC
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
Celgene